Intraobserver and interobserver variability in distinguishing between endocervical and endometrial adenocarcinoma on problematic cases of cervical curettings

International Journal of Gynecological Pathology

Volumn 27, Issue 3, 2008, Pages 431-436

  Mhawech Fauceglia, Paulette ^a   Herrmann, Francois ^b   Bshara, Wiam ^a   Zhang, Shaozeng ^a   Penetrante, Remedios ^a   Lele, Shashikant ^a   Odunsi, Kunle ^a   Rodabaugh, Kerry ^a  

^a ROSWELL PARK CANCER INSTITUTE   (United States)

^b GENEVA UNIVERSITY HOSPITALS   (Switzerland)

Author keywords

Endocervical adenocarcinoma; Endometrial adenocarcinoma; Intraobserver and interobserver variability

Indexed keywords

ARTICLE; CLINICAL ARTICLE; CLINICAL EVALUATION; CLINICAL TRIAL; CONTROLLED STUDY; ENDOMETRIUM CARCINOMA; FEMALE; GROUPS BY AGE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTERRATER RELIABILITY; INTRARATER RELIABILITY; MORPHOLOGICAL TRAIT; PRIORITY JOURNAL; UTERINE CERVIX CARCINOMA; VAGINAL HYSTERECTOMY; ADENOCARCINOMA; CURETTAGE; ENDOMETRIUM TUMOR; HYSTERECTOMY; OBSERVER VARIATION; PATHOLOGY; PROSPECTIVE STUDY; UTERINE CERVIX; UTERINE CERVIX TUMOR;

ADENOCARCINOMA; CERVIX UTERI; CURETTAGE; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; HYSTERECTOMY; IMMUNOHISTOCHEMISTRY; OBSERVER VARIATION; PROSPECTIVE STUDIES; UTERINE CERVICAL NEOPLASMS;

EID: 50349088113     PISSN: 02771691     EISSN: None     Source Type: Journal    
DOI: 10.1097/PGP.0b013e3181601792     Document Type: Article

References (19)

1. Berek JS, Hacker NV. Practical Gynecologic Oncology, 3rd ed. Philadelphia: Lippincott Williams and Wilkins; 2000.
2. Hoskins WJ, Perez CA, Young RC. Principles and Practice of Gynecologic Oncology. Philadelphia: JB Linppincott; 1992.
3. Kamoi S, AlJuboury M, Akin M-R, et al. Immunohistochemical staining in the distinction between primary endometrial and endocervical adenocarcinoma: another viewpoint. Int J Gynecol Pathol 2002;21:217-223
4. McCluggage WG, Sumathi VP, McBride HA, et al. A panel of immunohistochemical stains, including carcinoembryonic antigen, vimentin, and estrogen receptor, aids the distinction between primary endometrial and endocervical adenocarcinomas. Int J Gynecol Pathol 2001;21:11-15.
5. Castrillon DH, Lee KR, Nucci MR. Distinction between endometrial and endocervical adenocarcinoma: an immunohistochemical study. Int J Gynecol Pathol 2001;21:4-10.
6. Sirvidis E, Giatromanolaki A, Koukourakis MI, et al. Patterns of episialin/MUC1 expression in endometrial carcinomas and prognostic relevance. Histopathology 2002; 40:92-100.
7. Hebbar V, Damera G, Sachdev GP. Differential expression of MUC genes in endometrial and cervical tissues and tumors. BMC Cancer 2005;5:124.
8. Khoury T, Tan D, Wang J, et al. Inclusion of MUC1 (Ma695) in a panel of immunohistochemical markers is useful for distinguishing between endocervical and endometrial mucinous adenocarcinoma. BMC 2006;6:1-9.
9. Ansari-Lari MA, Staebler A, Zaino RJ, et al. Distinction of endocervical and endometrial adenocarcinomas. Immunohistochemical p16 expression correlated with human papillomavirus (HPV) DNA detection. Am J Surg Pathol 2004;28: 160-167
10. Silverberg SG, Kurman RJ, Nogales F, et al. Pathology and Genetics Tumors of the Breast and Female Genital Organs. Tavassoli F, ed. Lyon, France: World Health Organization IARC; 2003.
11. Zaino RJ. The fruits of our labors: distinguishing endometrial from endocervical adenocarcinoma. Int J Gynecol Pathol 2002; 21:1-3.
12. Dabbs D, Strurtz K, Zaino R. The immunohistochemical discrimination of endometrioid adenocarcinomas. Hum Pathol 1996;27:172-177
13. Dabbs D, Geisinger L. Selective applications of immunohistochemistry in gynecological neoplasms. Pathol Annu 1993; 28(pt 1):329-353
14. Ohwada M, Suzuki M, Tamada T. Immunohistcochemical investigation of vimentin of uterine endometrial and endocervical adenocarcinoma. Nippon Sanka Fujinka Gakkai Zasshi 1990;42:1237-1243
15. Massood S, Rhatigan R, Wilkinson E, et al. Expression and prognostic significance of estrogen and progesterone receptors in adenocarcinoma of the uterine cervix. Cancer 1993;72: 511-518
16. Ghandour F, Attanoos R, Nahar K, et al. Immunohistocytochemical localization of estrogen and progesterone receptors in primary adenocarcinoma of the cervix. Histopathology 1994;24:49-55.
17. Fujiwara H, Tortolero G, Mitchell M, et al. Adenocarcinoma of the cervix: expression and clinical significance of estrogen and progesterone receptors. Cancer 1997;79:505-512
18. Reid-Nicholson M, Iyengar P, Hummer AJ, et al. Immunophenotypic diversity of endometrial adenocarcinomas: implications for differential diagnosis. Mod Pathol 2006;19: 1091-2000.
19. McCluggage WG, Jenkins D. p16 immunoreactivity may assist in the distinction between endometrial and endocervical adenocarcinoma. Int J Gynecol Pathol 2003;22:231-235